Sign In
Buy RPRX
$53.57
+0.610 (+1.15%)
At Close: Jun 22, 2026
Three Stock Lunch: Ally Financial, Amazon and Royalty Pharma
03:46pm, Tuesday, 16'th Aug 2022
Eva Ados, ERShares chief investment strategist, joins 'Power Lunch' to discuss her take on three stocks: Ally Financial, Amazon and Royalty Pharma.
Warren Buffett Ramps Up Occidental and Apple Stakes, Dumps Verizon
06:35pm, Monday, 15'th Aug 2022
Warren Buffett (Trades, Portfolio)'s multibillion-dollar conglomerate, Berkshire Hathaway Inc. ( BRK.A , Financial)( BRK.B , Financial), disclosed its equity portfolio for the second quarter of 2022 o
Buffett's Berkshire more than triples Ally stake, sheds Verizon
04:46pm, Monday, 15'th Aug 2022
Warren Buffett's Berkshire Hathaway Inc on Monday said it more than tripled its stake in the online banking company Ally Financial Inc, while shedding its stakes in Verizon Communications Inc and Roya
Royalty Pharma's (RPRX) CEO Pablo Legorreta on Q2 2022 Results - Earnings Call Transcript
02:09pm, Thursday, 04'th Aug 2022
Royalty Pharma plc (NASDAQ:RPRX ) Q2 2022 Earnings Conference Call August 4, 2022 8:00 AM ET Company Participants George Grofik - SVP, Head, IR & Communications Pablo Legorreta - Founder & CEO Marshal
Royalty Pharma (RPRX) Tops Q2 Earnings and Revenue Estimates
10:32am, Thursday, 04'th Aug 2022
Royalty Pharma (RPRX) delivered earnings and revenue surprises of 1.28% and 2.37%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?
Royalty Pharma (RPRX) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
11:47am, Thursday, 28'th Jul 2022
Royalty Pharma (RPRX) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Blueprint inks deal with Sixth Street, Royalty Pharma worth up to $1.2 billion
08:42am, Thursday, 30'th Jun 2022
Shares of Blueprint Medicines Corp. BPMC, -2.34% gained 3.3% in premarket trading on Thursday after the company announced a deal with investment firm Sixth Street and Royalty Pharma RPRX, -1.10% , whi
Royalty Pharma (RPRX) Surges 5.2%: Is This an Indication of Further Gains?
07:42am, Monday, 27'th Jun 2022
Royalty Pharma (RPRX) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price incre
Royalty Pharma to Present at the Goldman Sachs 43rd Annual Global Healthcare Conference
08:30am, Wednesday, 08'th Jun 2022
NEW YORK, June 08, 2022 (GLOBE NEWSWIRE) -- Royalty Pharma plc (Nasdaq: RPRX) today announced that it is scheduled to present at the Goldman Sachs 43rd Annual Global Healthcare Conference on June 14,
Royalty Pharma: Unique Diversification, Bear Market Performer
08:16am, Thursday, 26'th May 2022
Royalty Pharma lets you diversify within the healthcare sector. A bear market is actually conducive to its business model.
Royalty Pharma to Present at the UBS Global Healthcare Conference 2022
08:30am, Monday, 23'rd May 2022
NEW YORK, May 23, 2022 (GLOBE NEWSWIRE) -- Royalty Pharma plc (Nasdaq: RPRX) today announced that it is scheduled to present at the UBS Global Healthcare Conference 2022 on May 24, 2022 at 1:15 p.m. E
Here's Every Stock Warren Buffett Bought or Sold in the First Quarter
06:08am, Tuesday, 17'th May 2022
The Oracle of Omaha was very active in the markets.
Royalty Pharma plc (RPRX) Management on Q1 2022 Results - Earnings Call Transcript
02:09pm, Thursday, 05'th May 2022
Royalty Pharma plc (NASDAQ:RPRX ) Q1 2022 Earnings Conference Call May 5, 2022 8:00 AM ET Company Participants George Grofik - Senior Vice President, Head-Investor Relations & Communications Terry Coy
Royalty Pharma (RPRX) Reports Next Week: Wall Street Expects Earnings Growth
04:35pm, Thursday, 28'th Apr 2022
Royalty Pharma (RPRX) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Royalty Pharma to Announce First Quarter 2022 Financial Results on May 5, 2022
08:00am, Wednesday, 13'th Apr 2022
NEW YORK, April 13, 2022 (GLOBE NEWSWIRE) -- Royalty Pharma plc (Nasdaq: RPRX) today announced that it will report its first quarter 2022 financial results on Thursday, May 5, 2022 before the U.S. fin
